Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding (PERICOLL)
Sponsor: Nantes University Hospital
This observational or N/A phase trial investigates Von Willebrand Disease and is currently completed. Nantes University Hospital leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2022 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jul 2022 [monthly]
Completed
-
May 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 5 earlier versions
-
Mar 2019 — May 2020 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Feb 2019 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Nantes University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .